Gilead Sciences, Inc. announced the pricing of senior unsecured notes in an aggregate principal amount of $2 billion, in an underwritten, registered public offering, consisting of $1 billion of 5.250% senior notes maturing in 2033 and $1 billion of 5.550% senior notes maturing in 2053.
Gilead Prices $2 Billion of Senior Unsecured Notes Read More »
Burning Rock Biotech Limited is delighted to announce that our personalized Minimal Residual Disease product, CanCatch®, was enrolled in a prospective observational study.
The report from Fair Health comes after lawmakers this summer reintroduced legislation to make pandemic-era telehealth flexibilities permanent.
The appointments come less than a month after the company elevated Ivan Tornos to the CEO position.
The company will pay more than $479 million to resolve all economic loss claims. The settlement does not include injury or medical monitoring claims.
Philips reaches settlement in US respiratory device litigation Read More »
Thirty-two percent of people appointed to positions at the HHS between 2004 and 2020 exited to the private sector, raising concerns about objectivity, according to new research.
‘Revolving door’ between HHS and industry could influence regulation, study says Read More »
Only 40% of nursing homes nationwide complied with reporting requirements between 2016 and 2021, despite nursing homes being among the most dangerous workplaces in America, according to the Health Affairs study.
Unionized nursing homes more likely to report workplace injuries and accidents Read More »
Los avances científicos y tecnológicos ayudan cada vez más a demostrar legalmente crímenes contra la humanidad y obtener pruebas de actos de ese tipo que de otro modo quedarían impunes. En el caso de la última dictadura argentina, tales avances fueron esenci …
Ciencia y derechos humanos: un método contra el negacionismo Read More »
Contrary to the drugmaker’s expectations, its top-selling cancer medicine Xtandi wasn’t picked as one of the first 10 drugs to face price negotiations.
Astellas withdraws lawsuit challenging Medicare drug price program Read More »
La enfermedad de Alzheimer es un trastorno neurodegenerativo progresivo, siendo el principal factor de riesgo la edad. La mayoría de los casos de enfermedad de Alzheimer son esporádicos, sin una causa subyacente conocida, y apenas un 5% de los casos son casos familiares en los que se c …
